Agreement - January 20, 2021
Recipharm signs manufacturing agreement with Enzymatica
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme. The agreement will involve an additional Recipharm production site in Pianezza, Italy, to support Enzymatica in increasing production volumes of ColdZyme to meet growing global demand. Both the facilities in Parets, Spain, and Pianezza, Italy, will be making additional investments to accommodate […]
Agreement - February 14, 2017
Enzymatica enters partnership agreement
Enzymatica enters into partnership agreement with STADA Arzneimittel which grants STADA exclusive rights to sell, market and distribute Enzymatica’s common cold product ColdZyme in Germany. Stada is a global pharmaceutical company, headquartered in Germany, with a strong presence in Europe and leading positions in the cough and cold category in Germany, UK, and Russia. “We […]
Agreement - January 28, 2016
Enzymatica and Zymetech sign agreement
Swedish Enzymatica has signed an agreement to acquire Icelandic company Zymetech via a non-cash issue. This acquisition gives Enzymatica international exclusive rights to a patent-protected enzyme, a key ingredient in ColdZyme Mouth Spray, as well as control over production of the enzyme, access to international research and development expertise and Zymetech’s portfolio. The capital contributed […]
Agreement - November 16, 2015
Enzymatica signs distribution agreement
Enzymatica has partnered with Esteve, a leading pharmaceutical company in Spain. The agreement provides Esteve with exclusive rights to sell, market and distribute ColdZyme to pharmacies in Spain and Andorra. The agreement covers Enzymatica’s products ColdZyme 20 ml and ColdZyme One Cold, 7 ml. In Spain the products will be sold under the co-brand Cortagrip/ColdZyme. “The […]
Agreement - October 13, 2014
Enzymatica expands in Denmark
Enzymatica has signed agreements with the pharmacy chain Pharma+ and the wellness chain Matas in Denmark to sell ColdZyme. From November this year, ColdZyme will be available on the Danish market, and thus in all of Scandinavia. “According to plan, we are expanding to our neighboring countries using our own sales organization, building a platform of […]
New Market - September 26, 2014
Enzymatica gets first order for veterinary products
The company’s partner Adartis Animal Health has placed a first order for the veterinary products that Enzymatica launched in the United States and Canada in July 2014. The order includes Kalvatin products to a value of about SEK 3 million. According to Enzymatica the order is expected to cover market needs for the next six to […]
